GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis-Reference-Cited by-同舟云学术

GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis

Published:2020-07-10 Issue:9 Volume:95 Page:399-401
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Maniscalco Giorgia Teresa,Mariotto Sara,Höftberger Romana,Capra Ruggero,Servillo Giovanna,Manzo Valentino,Napolitano Massimo,Candelaresi Paolo,Gerevini Simonetta,Ferrari Sergio,Bozzetti Silvia,Spatola Marianna,Florio Ciro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Reference7 articles.

1. Monitoring and management of autoimmunity in multiple sclerosis patients treated with alemtuzumab: practical recommendations;Devonshire;J Neurol,2018

2. Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients

3. Autoimmune encephalitis following alemtuzumab treatment of multiple sclerosis;Giarola;Mult Scler Relat Disord,2019

4. Investigations in GABAA receptor antibody-associated encephalitis

5. GABAA receptor autoimmunity

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers;Frontiers in Immunology;2024-07-03

2. Anti–GABA-A Receptor Antibody-Mediated Epilepsia Partialis Continua After Treatment With Alemtuzumab;Neurology Neuroimmunology & Neuroinflammation;2023-07

3. Regulation of the E/I-balance by the neural matrisome;Frontiers in Molecular Neuroscience;2023-04-18

4. Clinical-laboratory interaction in the diagnosis of autoimmune neurological conditions: focus on the COVID-19 pandemic;La Rivista Italiana della Medicina di Laboratorio;2023-01

5. Psychiatric manifestations of autoimmune encephalitis;Autoimmunity Reviews;2022-09